Navigation Links
Auxilium Pharmaceuticals, Inc, Announces Second Quarter 2013 Financial Results
Date:8/1/2013

a) 

17.8Research and development

13.6(0.7)

 (b) 

12.910.2(0.6)

 (b) 

9.5Selling, general and administrative

74.9(24.2)

 (c) 

50.742.6(3.2)

 (c) 

39.3Amortization of purchased intangibles

10.9(10.9)

 (d) 

---Contingent consideration

2.3(2.3)

 (e) 

---Total operating expenses

128.9(42.6)86.370.6(3.9)66.7Income (loss) from operations

(28.4)42.614.37.63.911.5Interest income (expense), net

(6.9)3.7

 (f) 

(3.2)0.1-0.1Income (loss) before Income taxes

(35.3)46.311.07.73.911.6Income tax benefit

92.4(92.4)

 (g) 

---Net income (loss)

$
57.1$  (46.1)$
.0$
7.7$
3.9$
.6Net income (loss) per common share:Basic$
.16$
.22$   0.16$
.24Diluted

$
.15$
.22$   0.16$
.24Shares used to compute net income (loss)per share:Basic49.349.348.648.6Diluted

49.649.649.249.2* Actient revenues are included for the time period from April 26, 2013 to June 30, 2013 3 Months3 Months Ended June 30, 2013Ended June 30, 2012Adjustments to:(a) Costs of goods sold:Employee stock-based compensation (1)$ (0.0)$ 0.0Acquired inventory step -up value (2)(4.5)-Total$ (4.5)$ 0.0(b) Research and development:Employee stock-based compensation (1)(0.7)(0.6)(c) Selling, general and administrative:Employee stock-based compensation (1)(3.5)(3.2)Acquisition related severence costs (3)(10.0)-Acquisition related transaction and integration costs (3)(10.7)-Total$ (24.2)$ (3.2)(d) Amortization of purchased intangibles (4)(10.9)-(e) Contingent consideration (5)(2.3)-(f) Interest income (expense), netNon-cash interest expense relatedto convertible debt and term loan (6)3.7-(g) Income tax benefit (7)(92.4)-(1)

The effects of emplo
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
2. Auxilium Pharmaceuticals to Announce First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10, 2012
3. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
4. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
5. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
6. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
7. Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results
8. Auxilium Pharmaceuticals to Announce Third Quarter 2012 Results and Conduct Conference Call on Wednesday, November 7, 2012
9. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
10. Auxilium Pharmaceuticals, Inc. Announces Offering of Convertible Senior Notes Due 2018
11. Auxilium Pharmaceuticals, Inc. Announces Pricing of $325.0 Million of 1.50% Convertible Senior Notes Due 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015 Hill-Rom,s recent ... $2 billion in cash and stock means the ... market, according to Kalorama Information. The healthcare market ... the medical device and advanced wound care markets, ... beds, patient lifting devices, and other healthcare equipment. ...
(Date:7/7/2015)... , July 7, 2015  Shareholder rights law ... a federal securities fraud class action complaint was ... Southern District of California.  The complaint alleges that ... CLDN ) violated the Securities Exchange Act of ... 2015, by making materially false and misleading statements ...
(Date:7/7/2015)... 7, 2015 According to ... Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, ... Alpha Emitters, Brachytherapy - Y-90), by Application (Oncology, ... by MarketsandMarkets, this report studies the global Nuclear ... to 2020. This market is expected to reach ...
Breaking Medicine Technology:Kalorama: Hill-Rom Enters Monitoring Market with Welch Allyn Purchase 2Kalorama: Hill-Rom Enters Monitoring Market with Welch Allyn Purchase 3Robbins Arroyo LLP: Celladon Corporation (CLDN) Misled Shareholders According to a Recently Filed Class Action 2Robbins Arroyo LLP: Celladon Corporation (CLDN) Misled Shareholders According to a Recently Filed Class Action 3Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 2Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 3Nuclear Medicine/Radiopharmaceuticals Market Worth $6.96 Billion by 2020 4
(Date:7/7/2015)... ... July 07, 2015 , ... Celestix Networks, the leading provider ... VA Series virtual appliances. These virtual platforms expand the existing physical appliances ... proven to simplify the on-premises deployment of unified remote access and single sign-on ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... global provider of advanced delivery technologies and development solutions for drugs, biologics ... licensing agreement with Excelimmune, Inc. to access its antibody combination therapy (ACT) ...
(Date:7/7/2015)... ... 2015 , ... The Immune Deficiency Foundation (IDF) launched a ... its IDF ePHR, an electronic personal health record powered by Get Real Health’s ... their health information, including symptoms, diagnoses, medications, infusions and other critical health data. ...
(Date:7/7/2015)... ... July 07, 2015 , ... On ... was the site of the National Baptist Convention 110th Annual Session of the ... and promoting the collaboration of churches and their congregations, medical professionals and health-related ...
(Date:7/7/2015)... ... July 07, 2015 , ... Dr. Poneh Ghasri ... whitening treatments. A professional teeth whitening is one of the fastest, easiest ways to ... as they can decrease smile satisfaction and confidence. With the right teeth whitening treatment, ...
Breaking Medicine News(10 mins):Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 4Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 3Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 2Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 3
... dead, without government ... Americans, DES MOINES, Iowa, Dec. 10 Print ads ... Nurses,Association (CNA)/National Nurses Organizing Committee (NNOC) is running,the ads as ... for all Americans through a Medicare-based system., The ad ...
... to Head Department, BANNOCKBURN, Ill., Dec. ... a contract research organization serving,pharmaceutical and biotechnology ... Wozniak, Ph.D., as Director, Statistical Programming. Dr.,Wozniak ... ACRS facilitates successful clinical trials by ...
... the Medicare End Stage Renal Disease Program Recommends,Policy ... Awareness, WASHINGTON, Dec. 10 The Association ... today,released a consensus report addressing proposed changes to ... are currently being considered by,the U.S. Congress., ...
... challenges traditional assessment of risk , , MONDAY, Dec. 10 ... at low risk for heart disease still face potential ... a new study suggests. , "Previous studies have demonstrated ... other populations," said study lead author Dr. Susan G. ...
... higher than dentists do, according to a new study. Teeth ... attractive face, the study also found, and people younger than ... published in this months Journal of the American Dental Association ... smiles on a 100-point satisfaction scale. Later, the patients regular ...
... and Nexium , , MONDAY, Dec. 10 (HealthDay News) ... heartburn drugs Prilosec and Nexium found no evidence of ... announcement followed a three-month safety review after reports of ... detailed data from both studies, plus another 14 studies, ...
Cached Medicine News:Health News:RNs Sponsor Hard-Hitting Health Care Ads in Top 10 Iowa Papers 2Health News:Advanced Clinical Research Services Enhances Biostatistics Offering 2Health News:Kidney Patients' Health Is Jeopardized by Proposed Medicare Changes 2Health News:Kidney Patients' Health Is Jeopardized by Proposed Medicare Changes 3Health News:Kidney Patients' Health Is Jeopardized by Proposed Medicare Changes 4Health News:Coronary Artery Calcium May Raise Women's Heart Risk 2Health News:FDA Confirms No Heart Risk From Heartburn Drugs 2Health News:FDA Confirms No Heart Risk From Heartburn Drugs 3
A single tube that performs two rapid tests for E. coli from culture. ColiScreen™ combines both the indole test with the glucuronidase test to increase the specificity....
Legionella provides rapid, accurate results that aid in the presumptive diagnosis of Legionella infection (Legionnaires' Disease)....
... The Trinity Biotech Captia™ ... Assay (ELISA) is intended for ... antibodies (IgG and IgM) to ... in serum from patients with ...
The GoodKnight® 425 Bi-Level® device is suitable for travel and includes features such as automatic altitude compensation, optional cigarette lighter adapter and portable battery pack...
Medicine Products: